Sign in

Katherine Thomasset

@kaththomasset.bsky.social
572 followers 1.1K following 409 posts

she/her Medical copy-editor at @diabetologiajnl.bsky.social, based at University of Bristol All views are my own

PostsRepliesMedia
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 14/10/2026
Our November issue is online! link.springer.com/journal/125/... @easdnews.bsky.social @springernature.com @springermedicine.com
The cover shows an illustration of 7 people at different life stages. The spotlight is shone on individuals across different stages of life, genders and ethnicities, all linked by metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes. MASLD is represented by lipid droplets (yellow circles) within the liver, while diabetes is depicted through the pancreas and key insulin target tissues (the liver, skeletal muscle and adipose tissue). The geometric, interconnected design reflects the complexity of inter-organ crosstalk and its dysregulation in these metabolic conditions.
061 6
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 12/10/2026
See the updated ADA and EASD consensus report on the management of #type2diabetes #EASD2026 link.springer.com/article/10.1... 🔓
link.springer.com
Management of type 2 diabetes, 2026. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) - Diabetologia
The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the consensus statement on the management of type 2 diabetes in non-pregnant adults,...
041 4
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 07/10/2026
Up front & free to read in our Oct issue #editorspicks: Type 2 diabetes subtypes for precision medicine: methodological challenges and alternative prediction‑based approaches link.springer.com/article/10.1...
031 3
Reposted by Katherine Thomasset
European Association for the Study of Diabetes @easdnews.bsky.social · 07/10/2026
👧 👦 Why is it so important for children with a genetic risk for #T2D to keep a healthy weight? 👉 The paper chosen by Dana Dabelea for this Gamechangers episode investigated the association between #GRS, #BMI and youth-onset #T2D. 📺 Watch here: easd-elearning.eu/episode/381/...
033 3
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 08/10/2026
New study shows empagliflozin and dapagliflozin have comparable risk of liver-related complications, with only marginally greater improvement in fatty liver with empagliflozin, in adults with type 2 diabetes and MASLD. #MASLD #SGLT2i #T2D #LiverHealth link.springer.com/article/10.1...
link.springer.com
Comparative hepatic effectiveness of empagliflozin vs dapagliflozin among individuals with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease - Diabetologia
Aims/hypothesis While both empagliflozin and dapagliflozin are known to improve hepatic steatosis and liver enzyme levels, robust phase 3 trial evidence for improving steatohepatitis and fibrosis is c...
031 3
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 08/10/2026
Up front & free to read in our Oct issue #editorspicks: A narrative review of what cohorts have taught us and how they have laid the foundation for much of our understanding of type 2 diabetes link.springer.com/article/10.1...
031 3
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 07/10/2026
A new #ExpertForum review reshapes our view of #InsulinResistance! Moving past uniform definitions, it presents IR as a dynamic, tissue-specific biological phenotype driven by metabolic stress & adaptation link.springer.com/article/10.1... 🔓 @adapubs.bsky.social
link.springer.com
Insulin resistance in the 21st century: new takes on an old problem—2025 Diabetes, Diabetes Care, and Diabetologia Expert Forum - Diabetologia
Insulin resistance is a hallmark of type 2 diabetes and several other metabolic diseases. However, efforts to improve insulin resistance are hindered by the biological complexity inherent to insulin a...
041 4
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 07/10/2026
GAD alum treatment delayed onset of stage 3 type 1 diabetes in autoantibody-positive children with HLA-DR3-DQ2. The findings support treatment based on genetic risk and highlight the need for further studies of GAD alum #T1D #Diabetes link.springer.com/article/10.1... 🔓
link.springer.com
Delayed time to stage 3 type 1 diabetes after GAD-alum treatment in HLA-DR3-DQ2-positive children: follow-up of the randomised placebo-controlled Diabetes Prevention – Immune Tolerance trial - Diabeto...
Aims/hypothesis The aim of this study was to assess the long-term treatment effects of alum-formulated human recombinant GAD65 (GAD-alum) after completion of the Diabetes Prevention – Immune Tolerance...
031 3
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 30/09/2026
In our 2026 special issue: Genetics of #MASLD: a #diabetes perspective link.springer.com/article/10.1... Pick up a print copy at #EASD2026 - only a few remaining! - or read the whole collection on our website
link.springer.com
Genetics of MASLD: a diabetes perspective - Diabetologia
Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent in people with type 2 diabetes and represents a major contributor to liver-related and extrahepatic morbidity and m...
051 5
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 29/09/2026
Meet the incoming Editor! Patrick Schrauwen will be at the Diabetologia/Metabologia stand to answer your questions Wednesday 11.30 CEST diabetologia-journal.org #EASD2026
041 4
Reposted by Katherine Thomasset
European Association for the Study of Diabetes @easdnews.bsky.social · 29/09/2026
📖 A cover that says it all! Explore the complexity of #MASLD and #diabetes in this special issue. Grab your print copy at the Diabetologia journal booth located in the Community Plaza (South Wing Level 0) at the Allianz MiCo - Milano Convention Centre.
033 3
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 29/09/2026
In our 2026 special issue: Understanding #MASLD and #diabetes through lived experience link.springer.com/article/10.1... Pick up a print copy at #EASD2026
link.springer.com
Understanding MASLD and diabetes through lived experience - Diabetologia
Diabetologia -
021 2
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 29/09/2026
Our special issue cover shines the light on people with #MASLD and #diabetes. The geometric, interconnected design reflects the complexity of inter-organ crosstalk and its dysregulation in these conditions diabetologia-journal.org/collections/... Pick up a print copy at #EASD2026
021 2
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 29/09/2026
In our 2026 special issue: The #liver in #diabetes: current state and future perspectives link.springer.com/article/10.1... Pick up a print copy at #EASD2026
link.springer.com
The liver in diabetes: current state and future perspectives - Diabetologia
Diabetes mellitus is strongly associated with metabolic dysfunction-associated steatotic liver disease (MASLD). For many years, MASLD has not been recognised as either a common pathophysiological feat...
051 5
Reposted by Katherine Thomasset
European Association for the Study of Diabetes @easdnews.bsky.social · 28/09/2026
🇮🇹 The doors are open! #EASD2026 is officially underway in Milan and Industry sessions are well underway. 🎟️ Reminder: Allow extra time for security checks and collect your badge early to avoid queues. 📸 Tag us in your photos and get featured on our social media wall: my.walls.io/easd2026 #diabetes
072 7
Reposted by Katherine Thomasset
European Association for the Study of Diabetes @easdnews.bsky.social · 18/09/2026
The latest issue of @diabetologiajnl.bsky.social is now available! New articles covering the latest in diabetes research. 🔗👉 Read the full issue here: link.springer.com/journal/125/... #DiabetesResearch #Diabetes #EASD2026 #medicaljournal
043 4
Reposted by Katherine Thomasset
Metabologia @metabologiajnl.bsky.social · 17/09/2026
Comment by Ng highlights 4 Metabologia & @diabetologiajnl.bsky.social papers, tracing an evidence-based pathway incl. a synthesis of interventions & programmes addressing #DiabetesDistress &, uniquely, perspectives of those with #LivedExperience. #diabetes #clinicalguidelines @easdnews.bsky.social
132 3
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 21/09/2026
A landmark moment for diabetes care: the first-ever @EASD Clinical Practice Guideline is now published in @diabetologiajnl.bsky.social . Assessing and managing #DiabetesDistress should be a core part of high-quality diabetes care link.springer.com/article/10.1... #PersonCentredCare
link.springer.com
2026 EASD evidence-based clinical practice guideline for assessing and managing diabetes distress among adults with type 1 diabetes or type 2 diabetes - Diabetologia
Diabetes distress is the emotional burden that arises from living with, and self-managing, diabetes. The aim of this clinical guideline is to optimise the assessment and management of diabetes distres...
032 3
Reposted by Katherine Thomasset
European Association for the Study of Diabetes @easdnews.bsky.social · 22/09/2026
📢🆕The @easdnews.bsky.social & ADA-endorsed statement on inpatient CGM, insulin pumps & AID systems in adults is now published in @diabetologiajnl.bsky.social & Diabetes Care. 📖 Read: link.springer.com/article/10.1... Presented at #EASD2026: 📅 1 Oct |🕒 15:45 | 📍Arena | 🎤1st-author Mikkel Thor Olsen
Infographic: International position statement on inpatient CGM, insulin pumps and automated insulin delivery in adults. Shows CGM target ranges for hospitalized non-critical patients and nine key topics - selection criteria, CGM metrics, insulin titration, perioperative care, alarm settings, staff training, EHR integration, imaging considerations, and discharge planning. Endorsed by EASD, ADA, JBDS-IP, and Australian Diabetes Society
043 4
Katherine Thomasset @kaththomasset.bsky.social · 23/09/2026
Freedom of speech is essential
000 0
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 23/09/2026
Structured lifestyle interventions promoted increases in physical activity in those with normoglycaemia and impaired glucose tolerance but not impaired fasting glucose #DiabetesResearch #T2D link.springer.com/article/10.1... 🔓️
link.springer.com
Differential physical activity responses to diabetes risk reduction interventions according to prediabetes phenotype in at-risk individuals: pooled analysis from three randomised controlled trials - Diabetologia
Aims/hypothesis Emerging research suggests that the effects of lifestyle interventions to reduce the risk of type 2 diabetes progression differ by prediabetes phenotype. We investigated whether this…
021 2
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 05/09/2026
Up front and free to read in our Sept issue #editorspicks: Metabolic state determines the brain and direct islet effects of liraglutide on enhanced insulin secretion doi.org/10.1007/s001...
021 2
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 11/09/2026
Single-cell profiling of pancreatic islets maps subtype-associated molecular alterations in type 2 diabetes, highlighting distinct endocrine stress and metabolic signatures across these clinical subgroups. #Diabetes #Subtype #scRNAseq link.springer.com/article/10.1... 🔒
031 3
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 15/09/2026
Can the nervous system influence overnight blood sugar control? Findings from a study using ECG-derived cardiac vagal tone and #CGM suggest that parasympathetic function may play an important role in glucose regulation during sleep #DiabetesResearch link.springer.com/article/10.1... 🔓
021 2
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 16/09/2026
New per-protocol results from the PROTECT trial show that teplizumab helps preserve beta cell function and supports better glucose management in children and adolescents newly diagnosed with stage 3 type 1 diabetes. #T1D #teplizumab #diabetesmanagement link.springer.com/article/10.1... 🔓
021 2
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 01/09/2026
Our Sept cover shows a mouse pancreatic islet (alpha cells in pink & beta cells in blue), highlighting single cell calcium responses to stimuli. In this issue, Hart et al report that SST inhibits insulin secretion by restraining alpha cell calcium and cAMP link.springer.com/article/10.1...
0115 11
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 03/09/2026
Up front and free to read in our Sept issue #editorspicks: SARS-CoV-2 and diabetes: a post-pandemic reappraisal doi.org/10.1007/s001...
021 2
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 03/09/2026
Over the past 50 years, cohort research has greatly advanced our understanding of the aetiology, determinants and comorbidities of type 2 diabetes, informed guideline development and complemented experimental studies link.springer.com/article/10.1... 🔓
021 2
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 01/09/2026
Review explores how high-resolution imaging, multi-omics and global collaborations are transforming our understanding of human islets and beta cell biology, while highlighting challenges in translating advances into therapies for type 1 diabetes. #T1D link.springer.com/article/10.1... 🔓
021 2
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 20/08/2026
LECT2 protects against diabetic retinopathy by restraining Müller cell-driven inflammation through the RPS27A–IκBα–NF-κB axis, highlighting a potential therapeutic pathway. #Diabetes #Retinopathy #LECT2 link.springer.com/article/10.1... 🔒
032 3
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 21/08/2026
Polygenic scores strongly predict type 1 #diabetes risk but their accuracy depends on genetic ancestry. A new review summarises efforts to develop novel #T1D polygenic scores that are highly accurate across diverse populations link.springer.com/article/10.1... 🔒
021 2
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 26/08/2026
#Type2Diabetes and the metabolic syndrome predict liver disease outcomes and CVD, the major cause of death in steatotic liver disease. Diabetologists play a key role in managing these individuals and identifying those at risk of advanced liver disease. #DDZ link.springer.com/article/10.1... 🔓
041 4
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 27/08/2026
GLP-1RA dulaglutide therapy is associated with greater improvements in glycaemic management and variability compared with insulin among adolescents with transfusion-dependent β-thalassaemia-induced diabetes, without compromising safety #DiabetesResearch link.springer.com/article/10.1... 🔓
021 2
Reposted by Katherine Thomasset
Prof Gavin Yamey MD MPH @gavinyamey.bsky.social · 26/08/2026
Letter from 130 bioethicists condemns the “unwarranted, ill-advised, & frankly bizarre vendetta against a scientist, Dr. Anthony Fauci, rather than making a sincere effort to learn from the painful experiences of the pandemic to improve national preparedness” bioethicstoday.org/blog/an-open...
bioethicstoday.org
Blog - An Open Letter of Support for Anthony Fauci from the Bioethics Community - Bioethics Today
As individuals concerned with ethics in science, medicine, and public health, we wish to express our dismay at the approach taken by Senate leaders to
13480122411 8K
Reposted by Katherine Thomasset
Metabologia @metabologiajnl.bsky.social · 20/08/2026
Meet our editorial board metabologia.org/editorial-board/ with expertise across various fields relating to diabetes and its complications, obesity, and metabolic aspects of other conditions - and all waiting for your submissions!
142 4
Reposted by Katherine Thomasset
UK Biobank @ukbiobank.ac.uk · 20/08/2026
'Healthy metabolism' gene could treat liver disease, diabetes and obesity 🧬 Researchers have discovered extremely rare genetic mutations that give people better blood sugar control, lower liver fat and healthier fat distribution. Learn more: ow.ly/Ng1950ZwFar
022 2
Reposted by Katherine Thomasset
European Association for the Study of Diabetes @easdnews.bsky.social · 13/08/2026
📖 The latest issue of @diabetologiajnl.bsky.social is now available! New articles covering the latest in diabetes #research. 🔗👉 Read the full issue here: link.springer.com/journal/125/... #Diabetes #EASD2026 #medicaljournal @springernature.com @springermedicine.com @hinmul.bsky.social
084 8
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 14/08/2026
Concurrent training during weight loss in type 2 diabetes enhances post-exercise ceramide clearance and fat oxidation capacity, suggesting improved lipid handling beyond diet alone. #Diabetes #Exercise #Lipidomics #Ceramides link.springer.com/article/10.1... 🔓
021 2
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 17/08/2026
Endometriosis was associated with a 46% increased risk of incident type 2 diabetes in a population-based cohort of nearly 3 million women, with differences observed across endometriosis subtypes. #Endometriosis #T2D link.springer.com/article/10.1... 🔓
021 2
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 12/08/2026
Our September issue is online now! link.springer.com/journal/125/... @easdnews.bsky.social @springernature.com @springermedicine.com @hinmul.bsky.social
A high-resolution image of a live murine pancreatic islet expressing the calcium indicator GCaMP6s in every islet cell. Alpha and beta cells are pseudocoloured in hot pink and grey blue, respectively.
051 5
Reposted by Katherine Thomasset
Metabologia @metabologiajnl.bsky.social · 29/07/2026
Precision diabetes medicine could reduce health disparities. In this scoping review (34 studies), Paul Franks and colleagues examine how health equity is addressed in the literature, highlighting the need for equity to be built in from the outset link.springer.com/article/10.1... 🔓
link.springer.com
Precision diabetes medicine and health equity: a scoping review - Metabologia
Aims/hypothesis Precision diabetes medicine aims to improve the accuracy of prevention and treatment by tailoring care to individuals and subgroups. When applied appropriately, it can reduce health di...
043 4
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 30/07/2026
#WeightLoss, #PhysicalActivity, #Nutrition, and #Sleep optimisation remain the cornerstones of #MASLD treatment. Read our review to see how #lifestyle change is not an adjunct to care, but the driving force behind meaningful and durable clinical outcomes link.springer.com/article/10.1... 🔓
031 3
Reposted by Katherine Thomasset
Metabologia @metabologiajnl.bsky.social · 30/07/2026
Study explores 24-h physical behaviours across age at diagnosis in individuals with type 2 diabetes link.springer.com/article/10.1... 🔓
link.springer.com
Age at diagnosis of type 2 diabetes and accelerometer-assessed 24-h physical behaviours: a cross-sectional pooled analysis - Metabologia
Aims/hypothesis We investigated the association between age at diagnosis of type 2 diabetes and accelerometer-assessed 24-h physical behaviours. Methods This cross-sectional study pooled data from thr...
032 3
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 01/08/2026
Our August cover illustrates immune cells rolling dice, representing clusters of diabetic complications. In this issue, Ding et al combine immune-cell transcriptomic data with Mendelian randomisation to identify causal genes for #T2D and its complications link.springer.com/article/10.1...
031 3
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 03/08/2026
Up front & free to read in our August issue #editorspicks: Olfactory dysfunction in obesity and type 2 diabetes: mechanistic insights from preclinical models doi.org/10.1007/s001...
043 4
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 02/07/2026
Up front & free to read in our July issue #editorspicks: From pancreas and islet resources to diabetes insights doi.org/10.1007/s001...
021 2
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 07/07/2026
Up front & free to read in our July issue #editorspicks: Endoplasmic reticulum–mitochondria contact sites are signalling hubs connecting nutrient sensing and GLP‑1 secretion in L cells of the mouse gut: from physiology to obesity and type 2 diabetes doi.org/10.1007/s001...
021 2
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 07/07/2026
#Metabolomics reveals key differences between LADA and #T1D, highlighting disease heterogeneity. #Tryptophan metabolism varies across #autoimmune conditions correlating positively with #β-cell function, suggesting role in disease progression. link.springer.com/article/10.1... 🔓
041 4
Katherine Thomasset @kaththomasset.bsky.social · 09/07/2026
Review exploring potential bidirectional relationship between COVID-19 and diabetes #COVID19 #DiabetesResearch
010 1
Reposted by Katherine Thomasset
Diabetologia @diabetologiajnl.bsky.social · 08/07/2026
Why does liraglutide work differently across patients? Metabolic state shifts its mode of action from brain tanycyte pathways in health to direct islet effects in #prediabetes. This offers a new framework for smarter #GLP-1R agonist use #T2D link.springer.com/article/10.1... 🔒
021 2